New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine

Free Radical Biology and Medicine

Volumn 36, Issue 1, 2004, Pages 1-15

  Hensley, Kenneth ^a,b   Benaksas, Elaine J ^d   Bolli, Roberto ^e   Comp, Philip ^b   Grammas, Paula ^c   Hamdheydari, Ladan ^c   Mou, Shenyun ^a   Pye, Quentin N ^a   Stoddard, Marcus F ^e   Wallis, Gemma ^a   Williamson, Kelly S ^a   West, Melinda ^a   Wechter, William J ^d   Floyd, Robert A ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d Encore Pharmaceuticals Inc   (United States)

^e University of Louisville School of Medicine   (United States)

Author keywords

Free radical; Inflammation; Nitric oxide; Vitamin E; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHROMAN DERIVATIVE; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; SCAVENGER; TOCOPHEROL DERIVATIVE;

ALPHA TOCOPHEROL DEFICIENCY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BINDING AFFINITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DATA ANALYSIS; DISEASE MODEL; DIURETIC ACTIVITY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EPIDEMIOLOGICAL DATA; EXPERIMENTAL ANIMAL; FERTILITY; HEART INFARCTION; HUMAN; IN VIVO STUDY; INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; METABOLITE; METHYLATION; NONHUMAN; PHYTOCHEMISTRY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; VITAMIN SUPPLEMENTATION;

ANIMALIA; MAMMALIA;

EID: 0347318119     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.10.009     Document Type: Review

References (88)

1. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1989;237-242 Clarendon Press, Oxford.
2. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha tocopherol and ascorbate. Arch. Biochem. Biophys. 300:1993;535-543.
3. Bieri J.G., Evarts R.P. Gamma tocopherol: metabolism, biological activity and significance in human vitamin E nutrition. J. Clin. Nutr. 27:1974;980-985.
4. Evans H.M., Bishop K.S. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science. 56:1922;650-651.
5. Bieri J.G., Evarts R.P. Vitamin E activity of γ-tocopherol in the rat, chick and hamster. J. Nutr. 104:1974;850-857.
6. Bunyan J., McHale D., Green J., Marcinkiewicz S. Biological potencies of epsilon and zeta-1 tocopherol and 5-methyltocol. Br. J. Nutr. 15:1961;253-257.
7. Century B., Horwitt M.K. Biological availability of various forms of vitamin E with respect to different indices of deficiency. Fed. Proc. 24:1965;906-911.
8. Burton G.W., Ingold K.U. Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc. 103:1981;6472-6477.
9. Hove E.L., Hove Z. The effect of temperature on the relative antioxidant activity of α-, β- and γ-tocopherols and of gossypol. J. Biol. Chem. 156:1944;623-632.
10. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., Mordan L.J. γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc. Natl. Acad. Sci. USA. 90:1993;1771-1775.
11. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., Ames B.N. γ-tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: physiological implications. Proc. Natl. Acad. Sci. USA. 94:1997;3217-3222.
12. Goss S.P.A., Hogg N., Kalyanaraman B. The effect of α-tocopherol on the nitration of γ-tocopherol by peroxynitrite. Arch. Biochem. Biophys. 363:1999;333-340.
13. 2 and their formation in rat insulinoma (RINm5F) cells. Free Radic. Biol. Med. 19:1995;259-260.
14. Hensley K., Maidt M.L., Pye Q.N., Stewart C.A., Wack M., Tabatabaie T., Floyd R.A. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. Anal. Biochem. 251:1997;187-195.
15. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R., Cooney R.V., Grammas P., Reimann-Philipp U., Floyd R.A., Hensley K. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide: Biol. Chem. 6:2002;221-227.
16. Dillard C.J., Gavino V.C., Tappel A.L. Relative antioxidant effectiveness of α-tocopherol and γ-tocopherol in iron-loaded rats. J. Nutr. 113:1983;2266-2273.
17. Saldeen T., Li D., Mehta J.L. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J. Am. Coll. Cardiol. 34:1999;1208-1215.
18. Liu M., Wallmon A., Olsson-Mortlock C., Wallin R., Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am.J. Clin. Nutr. 77:2003;700-706.
19. Hensley K., Williamson K.S., Floyd R.A. Determination of 3-nitrotyrosine and 5-nitro-gamma tocopherol by HPLC with electrochemical detection. Free Radic. Biol. Med. 28:2000;520-527.
20. Radomski R.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:1990;5193-5197.
21. Malinski T., Radomski M.W., Taha Z., Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem. Biophys. Res. Commun. 194:1993;960-965.
22. Riddell D.R., Graham A., Owen J.S. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. J. Biol. Chem. 272:1997;89-95.
23. Tran K., Chan A.C. Comparative uptake of alpha- and gamma-tocopherol by human endothelial cells. Lipids. 27:1992;38-41.
24. Spencer A.P., Carson D.S., Crouch M.A. Vitamin E and coronary artery disease. Arch. Intern. Med. 159:1999;1313-1320.
25. Gey K.F., Puska P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53(Suppl. 1):1991;326S-334S.
26. Stampfer M.J., Hennekens C.H., Manson J.E., Coldizt G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary artery disease in women. N. Engl. J. Med. 328:1993;1444-1449.
27. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456.
28. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. National Acad. Press, 2000: 188-283, http://www.books.nap.edu/catalog/9810.html .
29. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 328:1996;1156-1162.
30. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
31. Rapola J.M., Virtamo J., Ripatti S., Huttumen J.K., Albanes D., Taylor P.R., Heinonen O.P. Randomised trial of alpha tocopherol and beta carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 349:1997;1715-1720.
32. The alpha-tocopherol beta carotene cancer prevention study group: the effect of vitamin E and beta carotene on the incidence of long cancer and other cancers in male smokers. N. Engl. J. Med. 330:1994;1029-1035.
33. The heart outcomes prevention evaluation study investigators: vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med. 342:2000;154-160.
34. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet. 361:2003;2017-2023.
35. Stocker R. The ambivalence of vitamin E in atherogenesis. Trends Biol. Sci. 24:1999;219-223.
36. Handelman G.J., Machlin L.M., Fitch K., Weiter J.J., Dratz E.A. Oral α-tocopherol supplements decrease plasma γ-tocopherol levels in humans. J. Nutr. 115:1985;807-813.
37. Lehmann J., Martin H.L., Lashley E.L., Marshall M.W., Judd J.T. Vitamin E in foods from high and low linoleic acid diets. J. Am. Diet. Assoc. 86:1986;1208-1216.
38. Traber M.G., Burton G.W., Hughes L., Ingold K.U., Hidaka H., Malloy M., Kane J., Hyams J., Kayden H.J. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J. Lipid Res. 33:1992;1171-1182.
39. Burgon G.W., Traber M.G., Acuff R.V., Walters D.N., Kayden H., Hughes L., Ingold K.U. Human plasma and tissue α-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am. J. Clin. Nutr. 67:1998;669-684.
40. Gao R., Stone W.L., Huang T., Papas A.M., Qui M. The uptake of tocopherols by RAW264.7 macrophages. Nutr. J. 1:2002;2.
41. Stone W.L., Papas A.M., LeClair I.O., Qui M., Ponder T. The influence of dietary iron and tocopherols on oxidative stress and ras-p21 levels in the colon. Cancer Detect. Prev. 26:2002;78-84.
42. Kontush A., Spranger T., Reich A., Baum K., Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of α-carotene and γ-tocopherol. Atherosclerosis. 144:1999;117-122.
43. Ohrvall M., Sundlof G., Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J. Intern. Med. 239:1996;111-117.
44. Ruiz Rejón F., Martin-Pena G., Granado F., Ruiz-Galiana J., Blanco I., Olmedilla B. Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. Nutrition. 18:2002;26-31.
45. El-Sohemy A., Baylin A., Spiegelman D., Ascherio A., Campos H. Dietary and adipose tissue gamma-tocopherol and risk of myocardial infarction. Epidemiology. 13:2002;216-223.
46. Porrini M., Gentile M.G., Fidanza F. Biochemical validation of a self-administered semi-quantitative food-frequency questionnaire. Br. J. Nutr. 74:1995;323-333.
47. Brown A.J. Acute effects of smoking cessation on antioxidant status. J. Nutr. Biochem. 7:1996;29-39.
48. Morton L.W., Ward N.C., Croft K.D., Puddey I.B. Evidence for the nitration of γ-tocopherol in vivo: 5-nitro-γ-tocopherol is elevated in the plasma of subjects with coronary artery disease. Biochem. J. 364:2002;625-628.
49. Shishehbor M.H., Aviles R.J., Brenna M.L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney J.F. Jr., Penn M.S., Sprecher D.L., Vita J.A., Hazen S.L. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA. 289:2003;1675-1680.
50. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., Arai H., Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409:1997;105-108.
51. Ascherio A., Stampfer M.J., Colditz G.A., Rimm E.B., Litin L., Willett W.C. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J. Nutr. 122:1992;1792-1801.
52. White E., Kristal A.R., Shikany J.M., Wilson A.C., Chen C., Mares-Perlman J.A., Masaki K.H., Caan B.J. Correlates of serum alpha- and gamma-tocopherol in the Women's Health Initiative. Ann. Epidemiol. 11:2001;136-144.
53. Heinonne O.P., Albanes D., Virtamo J., Taylor P.R., Huttunen J.K., Hartman A.M., Haapakoski J., Malila N., Rautalahti M., Ripatti S., Maenpaa H., Teerenhovi L., Koss L., Virolainen M., Edwards B.K. Prostate cancer and supplementation with alpha tocopherol and beta carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Inst. 90:1998;440-446.
54. Hartman T.J., Albanes D., Pietine P., Hartmann A.M., Rautalahti M., Tangrea J.A., Taylor P.R. The association between baseline vitamin E, selenium, and prostate cancer in the alpha tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol. Biomarkers Prev. 7:1998;335-340.
55. Eichholzer M., Stahelin H.B., Ludin E., Bernasconi F. Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective basel study. Prostate. 38:1999;189-198.
56. Malila N., Vertamo J., Virtanen M., Pietinen P., Albanes D., Teppo L. Dietary and serum alpha tocopherol, beta carotene and retinol, and risk for colorectal cancer in male smokers. Eur. J. Clin. Nutr. 56:2002;615-621.
57. Sato R., Helzlsouer K.J., Alberg A.J., Hoffman S.C., Norkus E.P., Comstock G.W. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 11:2002;451-457.
58. Huang H.-Y., Alberg A.J., Norkus E., Hoffman S.C., Comstock G.W., Helzlsouer K.J. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am. J. Epidemiol. 157:2003;335-344.
59. Gysin R., Azzi A., Visarius T. Gamma tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 16:2002;1945-1952.
60. Gann P.H., Ma J., Giovannuci E., Willett W., Sacks F.M., Hennekens C.H., Stampfer M. J. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59:1999;1225-1230.
61. Smith C.D., Carney J.M., Starke-Ree P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
62. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Lovell M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
63. Hensley K., Maidt M.L., Yu Z.Q., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:1998;8126-8132.
64. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: the Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336:1997;1216-1222.
65. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer's disease. JAMA. 287:2002;3223-3229.
66. Gurney M.E., Cutting F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., Hall E.D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
67. Li Y., Liu L., Barger S.W., Mrak R.E., Griffin W.S. Vitamin E suppression of microglial activation is neuroprotective. J. Neurosci. Res. 66:2001;163-170.
68. in t'Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M., Stricker B.H. Nonsteroidal anti-inflammatory drugs and risk of Alzheimer's disease. N. Engl. J. Med. 345:2001;1515-1521.
69. 2 within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. USA. 95:1998;2175-2179.
70. Infante J.P. A function for the vitamin E metabolite α-tocopherol quinone as an essential enzyme cofactor for the mitochondrial fatty acid desaturates. FEBS Lett. 446:1999;1-5.
71. Jiang Q., Elson-Schwab I., Courtemanche C., Ames B.N. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA. 97:2000;11494-11499.
72. Jiang Q., Ames B.N. γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 17:2003;816-822.
73. Jiang Q., Lykkesfeldt J., Shigenaga M.K., Shigeno E.T., Christen S., Ames B.N. Gamma tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic. Biol. Med. 33:2002;1534-1543.
74. Brigelius-Flohe R., Traber M.G. Vitamin E: Function and metabolism. FASEB J. 13:1999;1145-1155.
75. Birringer M., Drogan D., Brigelius-Flohe R. Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation. Free Radic. Biol. Med. 31:2001;226-232.
76. Schultz M., Leist M., Petrzika M., Gassmann B., Brigelius-Flohe R. Novel urinary metabolite of alpha tocopherol, 2,4,7,8-tetramethyl- 2(2′carboxyethyl)-6-hydroxychroman, as an indicator of adequate vitamin E supply? Am. J. Clin. Nutr. 62(6, Suppl):1995;1527S-1534S.
77. Traber M.G., Elsner A., Brigelius-Flohe R. Synthetic as compared with natural vitamin E is preferentially excreted as α-CEHC in human urine; studies using deuterated α-tocopherol acetates. FEBS Lett. 437:1998;145-148.
78. Wechter, W. J.; Kantoci, D.; Murray Jr., E. D.; D'Amico, D. C.; Jung, M. E.; Wang, W.-H. A new endogenous natriuretic factor: LLU-alpha. Proc. Natl. Acad. Sci. USA 93:6002-6007.
79. Murray E.D. Jr., Wechter W.J., Kantoci D., Wang W.H., Pham T., Quiggle D.D., Gibson K.M., Leipold D., Anner B.M. Endogenous natriuretic factors 7: biospecificity of a natriuretic γ-tocoopherol metabolite LLU-α J. Pharmacol. Exp. Ther. 282:1997;657-662.
80. Murray E.D. Jr., Kantoci D., DeWind S.A., Bigornia A.E., D'Amico D.C., King J.G. Jr., Pham T., Levine B.J., Jung M.E., Wechter W.J. Endogenous natriuretic factor 3: isolation and characterization of human natriuretic factors LLU-alpha, LLU-beta 1, and LLU-gamma. Life Sci. 57:1995;2145-2161.
81. Kantoci D., Wechter W.L., Murray E.D. Jr., Dewind S.A., Borchardt D., Khan S.I. Endogenous natriuretic factors 6: the stereochemistry of a natriuretic γ-tocopherol metabolite LLU-α J. Pharmacol. Exp. Ther. 282:1997;648-656.
82. Sontag T.J., Parker R.S. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism: novel mechanism of regulation of vitamin E status. J. Biol. Chem. 277:2002;25290-25296.
83. Landes N., Pfluger P., Kluth D., Birringer M., Ruhl R., Bol G.F., Glatt H., Brigelius-Flohe R. Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 65:2003;269-273.
84. Hensley K., Fedynyshyn J., Ferrel S., Floyd R.A., Gordon B., Grammas P., Hamdheydari L., Mhatre M., Mou S., Pye Q.N., Stewart S., West M., West S., Williamson K.S. Message and protein level elevations of tumor necrosis factor alpha (TNFα) and TNF-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 14:2003;74-80.
85. Chen M., Onal V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., Bian J., Guo L., Farrel L.A., Hersch S.M., Hobbs W., Vonsattel J.P., Cha J.H., Friedlander R.M. Minocycline inhibits caspase 1 and caspase 3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6:2000;797-801.
86. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21:2001;2580-2588.
87. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome C release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:2002;74-78.
88. Morinobu T., Yoshikawa S., Hamamura K., Tamai H. Gas chromatography mass spectrometry analysis of carboxyetheyl-hydroxychroman metabolites of alpha- and gamma-tocopherol in human plasma. Free Radic. Biol. Med. 32:2002;333-340.